The overexpression of Drp1 has been associated with malignant oncocytic thyroid tumors, and genetic and pharmacological blockade of Drp1 activity has been reported to affect the migration and invasion of thyroid cancer cells, which is a characteristic of malignant tumors [75]. Here, DNM1L is linked to cancer.